biologics asia

News
WuXi Biologics to Invest S$80 Million to Establish a ,
WuXi Biologics to Invest S$80 Million to Establish a ,

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing...

Know More
Home - 5th Annual Biologics Manufacturing Asia 2018
Home - 5th Annual Biologics Manufacturing Asia 2018

Biologics Manufacturing Asia is THE ONLY biomanufacturing focused event in Asia-Pacific Join us to convene on the best biomanufacturing practices! Biologics Manufacturing Asia is THE ONLY biomanufacturing focused event in Asia-Pacific Join us to convene ,...

Know More
Speakers | Biologics Manufacturing Asia 2018
Speakers | Biologics Manufacturing Asia 2018

Koustuv Chatterjee, PhD, is the head of Sterile Liquid Commercialization group in Merck and Co, which is responsible for successful drug product development and commercialization of biologics, vaccines and sterile small molecul...

Know More
Biologics & Biosimilars Congress
Biologics & Biosimilars Congress

Fairjourney Biologics provides a range of assets and services on antibody engineering, discovery and production It has established partnerships with leading biotech and pharmaceutical compani Fairjourney Biologics is a fee-for-service company, complemented with risk sharing programs...

Know More
Biosimilars Congress | Asian Biosimilars | Biosimilars ,
Biosimilars Congress | Asian Biosimilars | Biosimilars ,

Asian Biosimilars 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics ,...

Know More
Locations | Medtronic
Locations | Medtronic

Find Medtronic locations, including our headquarters, main regional offices, key manufacturing, service, research and development facilities, and education centers...

Know More
Biologics Markets in China - giiresearch
Biologics Markets in China - giiresearch

China's demand for Biologics has grown at a fast pace in the past decade In the next decade, both production and demand will continue to grow...

Know More
Cancer Biologics Market Size & Share, 2014-2024 | ,
Cancer Biologics Market Size & Share, 2014-2024 | ,

Industry Insights The global cancer biologics market size is expected to reach USD 8760 billion by 2024 and is anticipated to grow on account of rising prevalence of cancer, increasing demand for biological and targeted drug therapi...

Know More
12th Asian Biologics and Biosimilars Congress Tokyo ,
12th Asian Biologics and Biosimilars Congress Tokyo ,

12th Asian Biologics and Biosimilars Congress 2018 Organizing Committee invites you to attend the largest assemblage of biologics and biosimilars researchers from around the globe during August 20 - 21, 2017 at Tokyo, Japan Asian Biosimilars Congress is a global annual event...

Know More
Table of Contents - BIO
Table of Contents - BIO

biologics, along with other biotech products in the fields of agriculture and energy, constitute the broader bio-industry 4 that is expected to grow as fast as 20 percent ,...

Know More
AJ Biologics Sdn Bhd | Quality , - Landing Page - AJB
AJ Biologics Sdn Bhd | Quality , - Landing Page - AJB

Creating a world without vaccine-preventable diseas At AJ Biologics, we believe in playing our part to advance the availability, accessibility and affordability of trusted vaccines, in our mission to create a world where no one suffers or dies from a vaccine preventable disease...

Know More
Bio-Logic Science Instruments - Potentiostat - Battery ,
Bio-Logic Science Instruments - Potentiostat - Battery ,

Designer & manufacturer of instruments for Electrochemistry (Potentiostat & EIS), Rapid-Kinetics & Spectroscopy, Battery Cycling, Material Testing....

Know More
The 5th Annual Biologics Manufacturing Asia 2018
The 5th Annual Biologics Manufacturing Asia 2018

The 5th Annual Biologics Manufacturing Asia 2018 Close Solutions & Servic Biologics Small Molecul Softgels Continuous Manufacturing Product Development Commercial Product Supply Supply Chain Management Fisher Clinical Servic Development Phase Early Development Late Development Approval and Post ,...

Know More
Biosimilars Market Share & Size | Industry Growth Report
Biosimilars Market Share & Size | Industry Growth Report

Biosimilars market to reach $26,5513 million by 2020 Biosimilars market is segmented across North America, Europe, Asia-Pacific and LAMEA Asia Pacific and LAMEA The key companies profiled in this report are Novartis (Sandoz), Synthon Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd...

Know More
3rd Annual Biosimilars & Biologics 2019 • BioTech Pharma ,
3rd Annual Biosimilars & Biologics 2019 • BioTech Pharma ,

On 21 & 22 March 2019, Porto will host the 3rd BioTech Pharma Summit: Biosimilars & Biologics 2019This year’s flagship event will gather top EU, US, Asia and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilars & biologics medicines sector...

Know More
Global Biologics & Biosimilars Market Sales, Size, Growth ,
Global Biologics & Biosimilars Market Sales, Size, Growth ,

The report also studies the Biologics & Biosimilars Sales market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions during same stated forecast to 2025...

Know More
Biologics and Biosimilars Market: Allied Market Research
Biologics and Biosimilars Market: Allied Market Research

The biologics and biosimilars market is segmented on the basis of type, application, and region Based on type, the market is divided into antibody, hormone, and growth-factor By application, it is categorized into tumor, diabetes, cardiovascular, hemophilia, and ,...

Know More
Biologics Manufacturing Asia 2019 - TradeIndia
Biologics Manufacturing Asia 2019 - TradeIndia

Biologics Manufacturing Asia 2019 aims to bring together the key players along the biologics production value at the Biomanufacturing Hub Of Asia – Singapore Singapore houses the 9 out of the top 10 big pharma companies that are intensively working on producing biologic drugs...

Know More
5th Annual Biologics Manufacturing Asia 2018, Suntec ,
5th Annual Biologics Manufacturing Asia 2018, Suntec ,

5th Annual Biologics Manufacturing Asia is organized by IMAPAC - Imagine your impact and will be held during Jan 30 - Feb 02, 2018 at Suntec Singapore International ,...

Know More
Distributors in Asia - BioLogics Inc - Ultrasonic Homogenizers
Distributors in Asia - BioLogics Inc - Ultrasonic Homogenizers

BioLogics - a USA manufacturer of Ultrasonic Homogenizers, Sonicators, Cell Disruptors, Probe Sonicators, Cell Disrupters, Sonifiers, Sonic Dismembrators The standard for the USP BP EP and JP is the OMNICON Antibiotic Zone Reader, Antibiotic Potency Testing, Zones of Inhibition, Fisher Lilly Antibiotic Zone Reader...

Know More
WuXi Biologics Receives Asia's CMO of 2017 from ,
WuXi Biologics Receives Asia's CMO of 2017 from ,

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover, develop and ....

Know More
Growth of Japanese Pharma Market Driven by Biologics and ,
Growth of Japanese Pharma Market Driven by Biologics and ,

CPhI Japan, organized by UBM EMEA and UBM Asia, returned to Tokyo for its 16 th edition on April 19–21, 2017 New research into the Japanese pharmaceutical market was released at the show...

Know More
Biologics Manufacturing (Feb 2019), Biologics ,
Biologics Manufacturing (Feb 2019), Biologics ,

The Biologics Manufacturing Asia, the conference will cover areas like gain critical insights from panel discussions featuring the industry's foremost experts and driven by questions from the audience to ensure that the most important challenges facing the sector are examined in detail...

Know More
Catalent Biologics And MGC Pharma Announce ,
Catalent Biologics And MGC Pharma Announce ,

Mike Jenkins, Vice President of Business Development, Catalent Biologics, Asia Pacific, added, “This agreement will allow Catalent to continue to grow its biologics development and manufacturing interests of multiple NBEs and biosimilars, particularly in the Asia Pacific market The collaboration with MGC Pharma fits Catalent’s strategy ,...

Know More
7th Biologics Manufacturing Asia 2020, January | CLocate
7th Biologics Manufacturing Asia 2020, January | CLocate

7th Biologics Manufacturing Asia 2020 will be held in Singapore in 2020 (Not Final) 7th Biologics Manufacturing Asia 2020 is a conference dedicated to the challenges faced in the Asian biologics manufacturing sector...

Know More
Patheon Careers & Global Job Opportunities
Patheon Careers & Global Job Opportunities

As the world leader in serving science, we empower our people to advance innovative technologies, develop meaningful solutions, and build rewarding careers With revenues of $20B and the largest investment in R&D in the industry, we give our 67,000 extraordinary minds the resources and opportunities to make significant contributions to the world...

Know More
Biologics Market Size Forecast | Industry Growth Report ,
Biologics Market Size Forecast | Industry Growth Report ,

Industry Insights The global biologics market size was valued at USD 2766 billion in 2015 These products represent cutting-edge research and ,...

Know More
Biologics Regulation in Asia - BioProcess International
Biologics Regulation in Asia - BioProcess International

Asia is the biologics market, which is growing Foreign companies and investors have begun entering Asia to tap into that growth Here I provide an overview of the biological products market in Asia and discuss some recent regulatory changes in the region JAPAN...

Know More
Biosimilars & Biologics 2018 • BioTech Pharma Summit
Biosimilars & Biologics 2018 • BioTech Pharma Summit

On 22 & 23 March 2018, Porto will host the 2nd BioTech Pharma Summit: Biosimilars & Biologics 2018This year’s flagship event will gather top EU, US, Asia and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilars & biologics medicines sector...

Know More
Samsung Biologics, Bobcat Brave Asia’s 2nd-Worst IPO ,
Samsung Biologics, Bobcat Brave Asia’s 2nd-Worst IPO ,

Aug 21, 2016· Samsung Biologics, which had sales of 913 billion won in 2015, applied for IPO approvals earlier this month It is a unit of Samsung C&T Corp, which operates amusement parks and is ,...

Know More
Get Solutions & Quotation